Following the description of the role of PNPLA3 rs738409 G-allele in CLD [15], common genetic variants have been extensively studied, as they may facilitate risk stratification, reveal therapeutic targets, and promote personalized therapy for CLD. This evidence concerns the gene PNPLA3 and congenital secretory chloride diarrhea 1.